Sonova Holding AG (LON: 0QPY)
London
· Delayed Price · Currency is GBP · Price in CHF 321.02
+2.32 (0.73%)
At close: Jan 31, 2025
Sonova Holding AG Revenue
Sonova Holding AG had revenue of 1.83B CHF in the half year ending September 30, 2024, a decrease of -0.73%. This brings the company's revenue in the last twelve months to 3.71B, up 1.71% year-over-year. In the fiscal year ending March 31, 2024, Sonova Holding AG had annual revenue of 3.63B, down -2.98%.
Revenue (ttm)
3.71B CHF
Revenue Growth
+1.71%
P/S Ratio
n/a
Revenue / Employee
204.24K CHF
Employees
18,151
Market Cap
16.83B GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 3.63B | -111.50M | -2.98% |
| Mar 31, 2023 | 3.74B | 374.50M | 11.13% |
| Mar 31, 2022 | 3.36B | 762.00M | 29.29% |
| Mar 31, 2021 | 2.60B | -315.00M | -10.80% |
| Mar 31, 2020 | 2.92B | 153.70M | 5.56% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |